Labcorp price to free cash flow LH

Market value divided by free cash flow over the last twelve months, since 2010.

Today, Oct 23, 2026: 23.1×
10-year median: 14.5×
Against its 10-year history: 96th; percentile: 0 is its lowest day, 100 its highest
10-year range: 8.6× to 24.8×
Peer median: 33.5×

Labcorp's price to free cash flow is 23.1× as of Oct 23, 2026.

That is above its ten-year median of 14.5×, higher than on 96% of days in the last ten years.

Over that time it ranged from 8.6× in Mar 2020 to 24.8× in Feb 2025.

The median for 10 diagnostics and research stocks of a similar size is 33.5×.

Price to free cash flow over time

median 14.5×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	23.1×	14.8×	23.6×
2025	15.2×	15.1×	24.8×
2024	22.9×	21.3×	24.0×
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	14.7×	11.8×	14.7×
2020	11.2×	8.6×	16.8×
2019	14.6×	10.8×	18.1×
2018	10.5×	10.5×	15.6×
2017	13.2×	12.2×	15.4×
2016	13.8×	12.2×	17.0×
2015	18.1×	14.5×	32.1×
2014	14.1×	10.8×	14.2×
2013	11.0×	9.7×	13.0×
2012	9.7×	9.3×	11.6×
2011	10.6×	9.8×	11.8×
2010	10.7×	8.3×	10.8×

Against its peers

Companies in Medical - Diagnostics & Research nearest Labcorp's size, closest first, today.

Company	Price to free cash flow
LHLabcorp	23.1×
DGXQuest Diagnostics	19.8×
MTDMettler-Toledo International	38.7×
MEDPMedpace	26.4×
RVTYRevvity	31.7×
ILMNIllumina	43.7×
IDXXIDEXX Laboratories	35.2×
WATWaters	112×
IQVIQVIA	21.1×
AAgilent Technologies	38.5×
BIOBio-Rad Laboratories	28.0×
Peer median	33.5×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Labcorp

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.